cdmo.directory
← Compare landing

ProBio vs Viralgen

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/probio/viralgen

CategoryProBioViralgen
Listed sitebothcdmo
SummaryProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.Viralgen is a CDMO specializing exclusively in cGMP AAV gene therapy manufacturing, with the world's largest dedicated AAV production capacity and a 100% success rate for IND/IMPD dossiers across 50+ gene therapy customers.
Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • In Vitro Pharmacology
  • Protein Engineering
  • Bioanalysis
  • Flow Cytometry Services
  • Immunogenicity Assays (ADA / NAb)
  • Analytical Method Development & Validation
  • Regulatory Affairs
  • EU EMA Regulatory Strategy
  • US FDA Regulatory Strategy
Modalities
  • AAV / Viral Vector Platform
  • Gene Therapy
  • Cell Therapy
  • mRNA
  • Vaccine
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • AAV / Viral Vector Platform
  • Gene Therapy
Indications
  • Infectious Disease
  • Rare Disease
Locations
  • United States, United States
  • Netherlands, Netherlands
  • South Korea, South Korea
  • Hong Kong, Hong Kong, China
  • Shanghai, Shanghai, China
  • Nanjing, Nanjing, China
  • Headquarters & Manufacturing, San Sebastián, Basque Country, Spain
Certifications
  • FDA · Identifier: US Food and Drug Administration
  • EMA · Identifier: European Medicines Agency
  • NMPA · Identifier: National Medical Products Administration
  • EMA · Identifier: AEMPS/EMA certified
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.